CLINICAL_TRIALS
trial_result
· 2009-06-11
Clinical Trial Update: Effects of Gluten Digestion With ALV003
Summary
A completed clinical trial evaluating ALV003, a gluten-digesting enzyme, for treating celiac disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alvine Pharmaceuticals Inc. | Conditions: Celiac Disease | Status: COMPLETED